Search research articles
Contact Us
Filters
Showing results (1-10 of 11) with videos related to
Page
of 2
Sort By:
Methods in Molecular Biology (Clifton, N.J.)
|
February 28, 2002
Proteolytic fragments of calcium-binding proteins
Richard D Brokx, Hans J Vogel
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
January 5, 2002
Designing peptide-based scaffolds as drug delivery vehicles
Richard D Brokx, Stuart K Bisland, Jean Gariépy
The Journal of Biological Chemistry
|
November 16, 2002
A stable human p53 heterotetramer based on constructive charge interactions within the tetramerization domain
Richard D Brokx, Eleonora Bolewska-Pedyczak, Jean Gariépy
Methods in Molecular Biology (Clifton, N.J.)
|
February 9, 2002
Calcium-binding proteins
Hans J Vogel, Richard D Brokx, Hui Ouyang
Journal of Molecular Biology
|
November 23, 2006
Tandem dimerization of the human p53 tetramerization domain stabilizes a primary dimer intermediate and dramatically enhances its oligomeric stability
Gregory M K Poon, Richard D Brokx, Michael Sung, et al.
Journal of Structural Biology
|
April 22, 2004
Backbone dynamic properties of the central linker region of calcium-calmodulin in 35% trifluoroethanol
Richard D Brokx, Ruud M Scheek, Aalim M Weljie, et al.
Biochemistry
|
November 26, 2003
Nuclear magnetic resonance-based dissection of a glycosyltransferase specificity for the mucin MUC1 tandem repeat
Richard D Brokx, Leigh Revers, Qinghong Zhang, et al.
Bioorganic & Medicinal Chemistry Letters
|
April 6, 2005
Mercaptoamide-based non-hydroxamic acid type histone deacetylase inhibitors
Sampath-Kumar Anandan, John S Ward, Richard D Brokx, et al.
Bioorganic & Medicinal Chemistry Letters
|
September 11, 2007
Design and synthesis of thiazole-5-hydroxamic acids as novel histone deacetylase inhibitors
Sampath-Kumar Anandan, John S Ward, Richard D Brokx, et al.
Molecular Cancer Therapeutics
|
December 24, 2010
ENMD-2076 is an orally active kinase inhibitor with antiangiogenic and antiproliferative mechanisms of action
Graham C Fletcher, Richard D Brokx, Trisha A Denny, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 11) with videos related to
Sort By:
Page
of 2
Methods in Molecular Biology (Clifton, N.J.)
|
February 28, 2002
Proteolytic fragments of calcium-binding proteins
Richard D Brokx, Hans J Vogel
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
January 5, 2002
Designing peptide-based scaffolds as drug delivery vehicles
Richard D Brokx, Stuart K Bisland, Jean Gariépy
The Journal of Biological Chemistry
|
November 16, 2002
A stable human p53 heterotetramer based on constructive charge interactions within the tetramerization domain
Richard D Brokx, Eleonora Bolewska-Pedyczak, Jean Gariépy
Methods in Molecular Biology (Clifton, N.J.)
|
February 9, 2002
Calcium-binding proteins
Hans J Vogel, Richard D Brokx, Hui Ouyang
Journal of Molecular Biology
|
November 23, 2006
Tandem dimerization of the human p53 tetramerization domain stabilizes a primary dimer intermediate and dramatically enhances its oligomeric stability
Gregory M K Poon, Richard D Brokx, Michael Sung, et al.
Journal of Structural Biology
|
April 22, 2004
Backbone dynamic properties of the central linker region of calcium-calmodulin in 35% trifluoroethanol
Richard D Brokx, Ruud M Scheek, Aalim M Weljie, et al.
Biochemistry
|
November 26, 2003
Nuclear magnetic resonance-based dissection of a glycosyltransferase specificity for the mucin MUC1 tandem repeat
Richard D Brokx, Leigh Revers, Qinghong Zhang, et al.
Bioorganic & Medicinal Chemistry Letters
|
April 6, 2005
Mercaptoamide-based non-hydroxamic acid type histone deacetylase inhibitors
Sampath-Kumar Anandan, John S Ward, Richard D Brokx, et al.
Bioorganic & Medicinal Chemistry Letters
|
September 11, 2007
Design and synthesis of thiazole-5-hydroxamic acids as novel histone deacetylase inhibitors
Sampath-Kumar Anandan, John S Ward, Richard D Brokx, et al.
Molecular Cancer Therapeutics
|
December 24, 2010
ENMD-2076 is an orally active kinase inhibitor with antiangiogenic and antiproliferative mechanisms of action
Graham C Fletcher, Richard D Brokx, Trisha A Denny, et al.
Page
of 2